VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $305,500 | +281.9% | 32,500 | +11.1% | 0.02% | +325.0% |
| Q3 2022 | $80,000 | -5.9% | 29,258 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $85,000 | -41.8% | 29,258 | -39.6% | 0.00% | -40.0% |
| Q1 2022 | $146,000 | +64.0% | 48,458 | +151.6% | 0.01% | +66.7% |
| Q4 2021 | $89,000 | -26.4% | 19,258 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $121,000 | +5.2% | 19,258 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $115,000 | -5.7% | 19,258 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $122,000 | -75.2% | 19,258 | -78.0% | 0.01% | -75.0% |
| Q4 2020 | $492,000 | -3.3% | 87,400 | 0.0% | 0.02% | -16.7% |
| Q3 2020 | $509,000 | -20.0% | 87,400 | -0.9% | 0.02% | -31.4% |
| Q2 2020 | $636,000 | +26.9% | 88,200 | -17.7% | 0.04% | -10.3% |
| Q1 2020 | $501,000 | +381.7% | 107,200 | +724.6% | 0.04% | +680.0% |
| Q4 2019 | $104,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |